BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31391393)

  • 1. A Pediatric Case of Relapsing Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab.
    Nara M; Saito M; Abe F; Komatsuda A; Wakui H; Takahashi N
    Intern Med; 2019 Dec; 58(24):3583-3587. PubMed ID: 31391393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis.
    Higashitani K; Yoshimi R; Sato Y; Watanabe T; Ihata A
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):87-92. PubMed ID: 34473835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report.
    Ide H; Shimizu T; Koike Y; Abe K; Shigematsu K; Nishihata S; Kojima K; Ichinose K; Kawakami A
    Medicine (Baltimore); 2022 Nov; 101(44):e31401. PubMed ID: 36343053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
    McBrien CN; Menzies-Gow A
    Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-onset of eosinophilic granulomatosis with polyangiitis without eosinophilia and eosinophilic infiltration under benralizumab treatment: A case report.
    Yonezawa H; Ohmura SI; Ohkubo Y; Otsuki Y; Miyamoto T
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):145-149. PubMed ID: 37243733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.
    Steinfeld J; Bradford ES; Brown J; Mallett S; Yancey SW; Akuthota P; Cid MC; Gleich GJ; Jayne D; Khoury P; Langford CA; Merkel PA; Moosig F; Specks U; Weller PF; Wechsler ME
    J Allergy Clin Immunol; 2019 Jun; 143(6):2170-2177. PubMed ID: 30578883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
    Wechsler ME; Akuthota P; Jayne D; Khoury P; Klion A; Langford CA; Merkel PA; Moosig F; Specks U; Cid MC; Luqmani R; Brown J; Mallett S; Philipson R; Yancey SW; Steinfeld J; Weller PF; Gleich GJ;
    N Engl J Med; 2017 May; 376(20):1921-1932. PubMed ID: 28514601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.
    Navarro-Mendoza EP; Tobón GJ
    Curr Rheumatol Rep; 2018 Apr; 20(5):23. PubMed ID: 29611001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan.
    Yamane T; Hashiramoto A
    Arthritis Res Ther; 2023 Jun; 25(1):110. PubMed ID: 37365612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Treatment with Mepolizumab for Coronary Spastic Angina Associated with Eosinophilic Granulomatosis with Polyangiitis.
    Takigawa Y; Fujiwara K; Tabuchi I; Kudo K; Hayashi K; Matsumoto S; Omori H; Matsuoka S; Mitsumune S; Watanabe H; Sato A; Sato K; Shibayama T
    Intern Med; 2023; 62(16):2389-2393. PubMed ID: 37587056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis.
    Pradhan RR; Nepal G; Mandal S
    Pulm Med; 2019; 2019():4376380. PubMed ID: 30941214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis.
    Condreay LD; Parham LR; Qu XA; Steinfeld J; Wechsler ME; Raby BA; Yancey SW; Ghosh S
    Rheumatol Int; 2020 Aug; 40(8):1301-1307. PubMed ID: 32009195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis.
    Ríos-Garcés R; Prieto-González S; Hernández-Rodríguez J; Arismendi E; Alobid I; Penatti AE; Cid MC; Espígol-Frigolé G
    Eur J Intern Med; 2022 Jan; 95():61-66. PubMed ID: 34535374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
    Nolasco S; Portacci A; Campisi R; Buonamico E; Pelaia C; Benfante A; Triggiani M; Spadaro G; Caiaffa MF; Scioscia G; Detoraki A; Valenti G; Papia F; Tomasello A; Crimi N; Scichilone N; Pelaia G; Carpagnano GE; Crimi C
    Front Immunol; 2023; 14():1204444. PubMed ID: 37457743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mepolizumab as a glucocorticoid-sparing agent in eosinophilic granulomatosis with polyangiitis (EGPA): is a lower dose sufficient?
    Vergles M; Matković Z; Lalić K; Trkanjec JT; Tudorić N
    J Asthma; 2021 Dec; 58(12):1675-1679. PubMed ID: 32962455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early add-on administration of mepolizumab and intravenous immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis.
    Ikeda T; Komatsu T; Yokoyama K; Takahashi K; Kawakami T
    J Dermatol; 2021 Apr; 48(4):529-532. PubMed ID: 33305381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of eosinophilic polyangiitis with granulomatosis that evolved to cardiac arrest due to advanced atrioventricular block.
    Sakurai Y; Oshikata C; Katayama T; Takagi S; Kaneko Y; Yo K; Kaneko T; Kubota H; Matsubara T; Tsurikisawa N
    Nagoya J Med Sci; 2023 Feb; 85(1):171-178. PubMed ID: 36923623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions.
    Ushio Y; Wakiya R; Kato M; Kameda T; Nakashima S; Shimada H; Mansour MMF; Sugihara K; Miyashita T; Kadowaki N; Dobashi H
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):327-332. PubMed ID: 33533698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother.
    Ueki Y; Oshikata C; Asai Y; Kaneko T; Tsurikisawa N
    Intern Med; 2020 Apr; 59(7):991-995. PubMed ID: 31813915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mepolizumab: Therapeutic strategy for a pediatric patient with eosinophilic granulomatosis with polyangiitis.
    Ozola L; Aleksejeva E; Stoldere D; Dāvidsone Z; Šantere R; Grantiņa I; Cīrule I; Krams A
    Pediatr Pulmonol; 2023 Mar; 58(3):973-979. PubMed ID: 36404638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.